Similar articles

• Advancing the battle against acute ischemic syndromes: a focus on the GP IIb-IIIa inhibitors.

  Dobesh PP, Latham KA. Dobesh PP, et al. Pharmacotherapy. 1998 Jul-Aug;18(4):663-85. Pharmacotherapy. 1998. PMID: 9692642 Review.
• Glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes.

  Zidar JP. Zidar JP. J Invasive Cardiol. 1999 Jun;11 Suppl A:13A-19A. J Invasive Cardiol. 1999. PMID: 10745606 Review. No abstract available.
• Glycoprotein IIb-IIIa antagonists in percutaneous coronary interventions and acute coronary syndromes.

  Ramanathan A, Kleiman NS. Ramanathan A, et al. Indian Heart J. 1998 Oct;50 Suppl 1:45-56. Indian Heart J. 1998. PMID: 9824907 Review. No abstract available.
• [Platelet glycoprotein IIB-IIIA receptor inhibitors in patients with ischemic heart disease].

  Patti G, Fossati C, Manzoli A, D'Ambrosio A, Abbate A, Montesanti R, Di Sciascio G. Patti G, et al. Clin Ter. 2000 Jul-Aug;151(4):301-6. Clin Ter. 2000. PMID: 11107681 Review. Italian.
• Perspectives on the future of platelet glycoprotein IIb/IIIa blockade therapy.

  Tcheng JE. Tcheng JE. Tex Heart Inst J. 1998;25(1):49-56. Tex Heart Inst J. 1998. PMID: 9566064 Free PMC article. Review.